Sera Prognostics hits near 2 year high as preterm birth test meets study goals

Sera Prognostics

06/12/2023 18:27

** Shares of Sera Prognostics  SERA.O  more than quadruple
to a near 2-yr high of $9.86; last up 232.4% in afternoon trade
    ** Stock set for its biggest one day pct rise, if gains hold
    ** Co says that its blood test to predict preterm birth
risks, PreTRM, met its primary goals, following which the
trial's data review board recommended stopping enrollment in the
study 
    ** SERA says it will stop enrollment to focus on analyzing
and reporting available data
    ** Including session's move, stock has soared more than
fivefold YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))